203 related articles for article (PubMed ID: 27484586)
21. Preparation, characterization and
Amer AM; Allam AN; Abdallah OY
Drug Dev Ind Pharm; 2019 Jul; 45(7):1140-1148. PubMed ID: 30912678
[TBL] [Abstract][Full Text] [Related]
22. Quantitative evaluation of the effect of poly(amidoamine) dendrimers on the porosity of epithelial monolayers.
Lin YL; Khanafer K; El-Sayed ME
Nanoscale; 2010 May; 2(5):755-62. PubMed ID: 20648321
[TBL] [Abstract][Full Text] [Related]
23. Poly(amidoamine) dendrimers as skin penetration enhancers: Influence of charge, generation, and concentration.
Venuganti VV; Perumal OP
J Pharm Sci; 2009 Jul; 98(7):2345-56. PubMed ID: 18937369
[TBL] [Abstract][Full Text] [Related]
24. Interaction between PAMAM-NH₂ G4 dendrimer and 5-fluorouracil in aqueous solution.
Buczkowski A; Sekowski S; Grala A; Palecz D; Milowska K; Urbaniak P; Gabryelak T; Piekarski H; Palecz B
Int J Pharm; 2011 Apr; 408(1-2):266-70. PubMed ID: 21335079
[TBL] [Abstract][Full Text] [Related]
25. Development and characterization of mixed niosomes for oral delivery using candesartan cilexetil as a model poorly water-soluble drug.
Sezgin-Bayindir Z; Antep MN; Yuksel N
AAPS PharmSciTech; 2015 Feb; 16(1):108-17. PubMed ID: 25204859
[TBL] [Abstract][Full Text] [Related]
26. Applying Different Techniques to Improve the Bioavailability of Candesartan Cilexetil Antihypertensive Drug.
Aly UF; Sarhan HA; Ali TFS; Sharkawy HAE
Drug Des Devel Ther; 2020; 14():1851-1865. PubMed ID: 32523332
[TBL] [Abstract][Full Text] [Related]
27. Binding free energy calculations using MMPB/GBSA approaches for PAMAM-G4-drug complexes at neutral, basic and acid pH conditions.
Martínez-Muñoz A; Bello M; Romero-Castro A; Rodríguez-Fonseca RA; Rodrigues J; Sánchez-Espinosa VA; Correa-Basurto J
J Mol Graph Model; 2017 Sep; 76():330-341. PubMed ID: 28759825
[TBL] [Abstract][Full Text] [Related]
28. Solubility and in vitro transdermal diffusion of riboflavin assisted by PAMAM dendrimers.
Filipowicz A; Wołowiec S
Int J Pharm; 2011 Apr; 408(1-2):152-6. PubMed ID: 21272625
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of phenylbutazone and poly(amidoamine) dendrimers interactions by a combination of solubility, 2D-NOESY NMR, and isothermal titration calorimetry studies.
Yang W; Li Y; Cheng Y; Wu Q; Wen L; Xu T
J Pharm Sci; 2009 Mar; 98(3):1075-85. PubMed ID: 18680167
[TBL] [Abstract][Full Text] [Related]
30. Solid self-microemulsifying formulation for candesartan cilexetil.
Nekkanti V; Karatgi P; Prabhu R; Pillai R
AAPS PharmSciTech; 2010 Mar; 11(1):9-17. PubMed ID: 20013081
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid.
Madaan K; Lather V; Pandita D
Drug Deliv; 2016; 23(1):254-62. PubMed ID: 24845475
[TBL] [Abstract][Full Text] [Related]
32. Dendritic chelating agents. 1. Cu(II) binding to ethylene diamine core poly(amidoamine) dendrimers in aqueous solutions.
Diallo MS; Christie S; Swaminathan P; Balogh L; Shi X; Um W; Papelis C; Goddard WA; Johnson JH
Langmuir; 2004 Mar; 20(7):2640-51. PubMed ID: 15835132
[TBL] [Abstract][Full Text] [Related]
33. The influence of PAMAM dendrimers surface groups on their interaction with porcine pepsin.
Ciolkowski M; Rozanek M; Bryszewska M; Klajnert B
Biochim Biophys Acta; 2013 Oct; 1834(10):1982-7. PubMed ID: 23851144
[TBL] [Abstract][Full Text] [Related]
34. Solid dispersion systems for enhanced dissolution of poorly water-soluble candesartan cilexetil: In vitro evaluation and simulated pharmacokinetics studies.
Ali ISM; Sajad UA; Abdul Rasool BK
PLoS One; 2024; 19(6):e0303900. PubMed ID: 38843120
[TBL] [Abstract][Full Text] [Related]
35. Three dimensional macroporous hydroxyapatite/chitosan foam-supported polymer micelles for enhanced oral delivery of poorly soluble drugs.
Zhang Y; Dong K; Wang F; Wang H; Wang J; Jiang Z; Diao S
Colloids Surf B Biointerfaces; 2018 Oct; 170():497-504. PubMed ID: 29960950
[TBL] [Abstract][Full Text] [Related]
36. Performance evaluation of PAMAM dendrimer based simvastatin formulations.
Kulhari H; Pooja D; Prajapati SK; Chauhan AS
Int J Pharm; 2011 Feb; 405(1-2):203-9. PubMed ID: 21145960
[TBL] [Abstract][Full Text] [Related]
37. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
[TBL] [Abstract][Full Text] [Related]
38. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers.
Yiyun C; Tongwen X
Eur J Med Chem; 2005 Nov; 40(11):1188-92. PubMed ID: 16153746
[TBL] [Abstract][Full Text] [Related]
39. Poly(amidoamine) dendrimers increase antifungal activity of clotrimazole.
Winnicka K; Sosnowska K; Wieczorek P; Sacha PT; Tryniszewska E
Biol Pharm Bull; 2011; 34(7):1129-33. PubMed ID: 21720026
[TBL] [Abstract][Full Text] [Related]
40. DEVELOPMENT OF SOLID LIPID NANOCARRIERS FOR ORAL DELIVERY OF CANDESERTAN CILEXETIL.
Ugurlu T; Nalbantoglu A; Sengel-Turk CT
Acta Pol Pharm; 2016 Nov; 73(6):1631-1638. PubMed ID: 29634119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]